Celltrion Pharm has ranked among the top searched stocks for 12 days in the past month.

As of 2:30 PM on the 11th, Celltrion Pharm is trading at 134,400 KRW, up 0.15% from the previous day. This represents a 60.77% increase compared to May 19. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.

Today, foreigners have sold a net 42,000 shares of Celltrion Pharm, while institutions have bought a net 7,000 shares, according to provisional data. Over the past five days, individual investors have sold a net 192,189 shares, while foreigners and institutions have bought net 178,544 shares and 13,699 shares, respectively.

On June 3, Celltrion Pharm became a market issue with headlines such as "Insulin injection development and consecutive days of COVID-19 treatment experiment results..."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing